Table 3.
Treatment cohort | Control cohort | Total | |||||
---|---|---|---|---|---|---|---|
EVD | Shunt | Total | EVD | shunt | total | ||
Staphylococcus spp. | 2 | 2 | 4 | 7 | 5 | 12 | 16 (55.2%) |
S. epidermidis | 2 | 2 | 4 | 7 | 4 | 11 | |
S. aureus | 0 | 0 | 0 | 0 | 1 | 1 | |
GNBs | 4 | 0 | 4 | 5 | 2 | 7 | 11 (37.9%) |
P. aeruginosa | 0 | 0 | 0 | 0 | 1 | 1 | |
Acinetobacter spp. | 2 | 0 | 2 | 1 | 0 | 1 | |
Enterobacter spp. | 1 | 0 | 1 | 1 | 0 | 1 | |
E. coli | 0 | 0 | 0 | 1 | 0 | 1 | |
Sphingomonas spp. | 1 | 0 | 1 | 0 | 0 | 0 | |
Klebsiella spp. | 0 | 0 | 0 | 2 | 1 | 3 | |
Other microorganisms | 4 | 0 | 4 | 3 | 1 | 4 | 8 (27.6%) |
Enterococcus spp. | 2 | 0 | 2 | 2 | 0 | 2 | |
Streptococcus spp. | 0 | 0 | 0 | 0 | 1 | 1 | |
Corynebacterium spp. | 1 | 0 | 1 | 1 | 0 | 1 | |
Candida spp. | 1 | 0 | 1 | 0 | 0 | 0 | |
Total (infection per procedure) | 6/47 (12.8%) | 2/72 (2.7%) | 8/119 (6.7%) | 13/65 (20%) | 8/47 (17%) | 21/112 (18.8%) | 29/231 (12.6%) |
EVD: external ventricular drain